Association of a 2-weeks-on and 1-week-off schedule of sunitinib with decreased toxicity in metastatic renal cell carcinoma.
Yana George Najjar
No relevant relationships to disclose
Paul Elson
No relevant relationships to disclose
Laura S. Wood
Honoraria - AVEO; Bayer/Onyx; Novartis; Pfizer
Jorge A. Garcia
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer
Robert Dreicer
Consultant or Advisory Role - Novartis
Brian I. Rini
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer